Lung Cancer Clinical Trials

Showing 3681-3700 of 4,288 trials

Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients

NCT01408212

This study aims for evaluating the effectiveness, safety and feasibility of additional acupuncture therapy for lung cancer patients who are under chemotherapy in an inpatient setting. The acupuncture therapy will be administered during a resting period between cycles of chemotherapy.

Lung Cancer

Korean Medicine Hospital of Pusan National University11 participantsStarted Jul 2011

Yangsan, Gyeongsangnam-do, South Korea

UNKNOWNPhase 1

A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC

NCT02321293

The purpose of this study is is to assess the safety and tolerability of curcumin in combination with EGFR-TKIs in selected patients with advanced non-resectable mutant EGFR NSCLC.

Lung Cancer

Lady Davis Institute20 participantsStarted Aug 2015

Montreal, Quebec, Canada

WITHDRAWNPhase 2

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

NCT01184287

The purpose of the trial is to determine the rate of improvement in objective tumor response, following the addition of ranpirnase to ongoing pemetrexed-carboplatin chemotherapy, for patients with SD or PR following 2 cycles of doublet chemotherapy.

Non-Small Cell Lung Cancer

Tamir Biotechnology, Inc.

Beverly Hills, California, United States • Grand Rapids, Michigan, United States • Great Falls, Montana, United States +3 more locations

Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients

A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

Related Searches

Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer

Expression and Sequence of Calcium Channels in Non-small Cell Lung Carcinoma (NSCLC)

Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors

Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer

Circulating Fibrocytes in Non-small Cell Lung Cancer.

Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer

Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation

Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy

A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Antinociceptive Modalities on Ischemia Reperfusion Injury

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer

Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)

Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients

Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC